Skip to main content
. 2020 May 16;92(3):535–542. doi: 10.1016/j.gie.2020.05.014

Table 3.

Indications related to ERCP

Procedural indication Critical patient-important outcome(s) Consensus time interval Consensus reached (%)
  • 15

    Painless jaundice with suspected biliary obstruction

Improvement/palliation of symptoms Within 1-8 weeks 91
  • 16

    Jaundice with suspected biliary obstruction, with abdominal pain (no cholangitis suspected)

Improvement/palliation of symptoms; avoidance of major surgery/hospitalization Within 1 week 69.2
  • 17

    Jaundice with suspected cholangitis

Avoidance of death/prolongation of life Within 1 week 100
  • 18

    No jaundice, but abnormal liver function test results and abdominal pain, with known/suspected choledocholithiasis ,

Avoidance of major surgery and/or hospitalization Within 1 week 70
  • 19

    Normal liver function test results and incidental finding of choledocholithiasis on imaging studies , ,

Avoidance of major surgery and/or hospitalization Defer >8 weeks, and reassess timing 83
  • 20

    Asymptomatic patient with pancreatic stent, for ERCP for stent removal

Avoidance of major surgery and/or hospitalization Defer >8 weeks, and reassess timing 75
  • 21

    Asymptomatic patients with plastic biliary stent for >3 months, for stent removal

Avoidance of major surgery and/or hospitalization Defer >8 weeks, and reassess timing 67
  • 22

    Postsurgical bile leak

Avoidance of major surgery and/or hospitalization Within 1 week 100
  • 23

    Patients with ampullary adenoma, for ampullectomy

Avoidance of cancer/avoidance of cancer progression; avoidance of major surgery and /or hospitalization Defer >8 weeks, and reassess timing 84.6
  • 24

    Patients with ampullary adenoma with high-grade dysplasia, for ampullectomy

Avoidance of cancer/avoidance of cancer progression; avoidance of major surgery and/or hospitalization Defer >8 weeks, and reassess timing 67
  • 25

    Patients with chronic pancreatitis with obstructing pancreatic duct stones and abdominal pain, for stone management

Avoidance of major surgery and/or hospitalization and Improvement or palliation of symptoms Defer >8 weeks, and reassess timing 92
  • 26

    Patient post liver transplant with unexplained increase in the results of liver function test or bilirubin level, anastomotic stricture suspected

Avoidance of major surgery and/or hospitalization Within 1-8 weeks 75

No consensus achieved on the first round of voting.

No consensus achieved on the second round of voting.

Consensus was achieved on the second round of voting.